Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Biotech And Medtech Portfolio Notes On A Fed Day
Article By:
Rod Raynovich
Wednesday, January 31, 2024 10:00 PM EDT
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
Pfizer Q4 Results: $14.25B In Revenue And EPS Of $0.1, Exceeding Forecasts
Article By:
The Tokenist
Tuesday, January 30, 2024 9:05 AM EDT
Pfizer reports Q4 2023 with strong financial results, achieving $14.25 billion in revenue and an EPS of $0.1.
In this article: PFE
Tuesday Talk: A Good Month - Two Days To Go
Article By:
David Marshall
Tuesday, January 30, 2024 6:22 AM EDT
With two trading days to go in January the major stock indices seem to be set to end the month at new highs and there are fewer analysts trying to insist that the "recession" is around the corner.
Markets Stroll Higher Ahead Of Key Data; SMCI, FFIV, WHR Beat
Article By:
Mark Vickery
Monday, January 29, 2024 10:20 PM EDT
One sign that we’re in a resilient bull market presently is that we’ve strolled into a potentially thorny period of economic and earnings data with market levels up more than a week straight, and we keep climbing further into the green
Daily Stock Pick: Pfizer (PFE)
I think #pfizer is overvalued. $PFE
Exact Sciences: Poised For Further Growth
Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS